9 mm 
61 mm 

O R IG IN A L A R T I C L E 
Cronos Pro Bold 
11 pt/ 13,2 pt - C0 M0 Y0 K0 
12 mm 
3 mm 180 x 265 mm 


11 mm 

Evaluation of great saphenous vein occlusion rate and clinical outcome 
in patients undergoing laser thermal ablation with a 1470-nm bare 
fiber laser with low linear endovenous energy density 

5 mm 

Avaliação da taxa de obliteração da veia safena magna e da evolução clínica de pacientes submetidos a termoablação com lase 1470 nm, fibra linear e baixa densidade de energia endovenosa linear 

4,5 mm 

Background: Water-specific 1470-nm lasers enable vein ablation at lower energy densities and with fewer side eects 
because they target interstitial water in the vessel wall. Objectives: To determine great saphenous vein (GSV) occlusion 
rate after thermal ablation with 1470-nm laser using 7W power and to evaluate clinical outcomes and complications. 
Method: Nineteen patients (31 GSVs) underwent thermal ablation. Follow-up duplex scanning, clinical evaluation 
using the Venous Clinical Severity Score (VCSS), and evaluation of procedure-related complications were performed 
Mean patient age was 46 years and 17 of the patients 
Cronos Pro Light 
9 pt/ 11 pt - C0 M0 Y0 K100 at 3-5 days after the procedure and at 30 and 180 days. Results:
were female (89.47%). Of 31 limbs treated, 2 limbs were clinical class C2, 19 were C3, 9 were C4, and 1 limb was C5 

Walter Junior Boim Araujo1, Jorge Rufino Ribas Timi1, Carlos Seme Nejm Júnior11, Filipe Carlos CaronCronos 
9 pt/ 11 pt - C0 M0 Y0 K100 
Cronos Pro Semibold 
11 pt/ 13 pt - C0 M0 Y0 K100 
1, , 

2,5 mm 
4 mm 


Abstract 

1,5 mm 

25,5 mm 
according to the Clinical-Etiology-Anatomy-Pathophysiology (CEAP) classification. Mean linear endovenous energy 
density was 33.53 J/cm. e GSV occlusion rate was 93.5% immediately after treatment, 100% at 3-5 days and 100% 
at 30 days after treatment and 87.1% 180 days after treatment. ere was a significant reduction in VCSS at all time 
points. Conclusions: e data from this study support the possibility that the incidence of complications can be 
reduced without significantly aecting the clinical outcomes, by using lower energy density. However, this appears to 
be at the cost of reduced ecacy in terms of GSV occlusion rates. 

2,5 mm 

Avaliação da taxa de obliteração da veia safena magna e da evolução clínica de 
pacientes submetidos a termoablação com laser 1470 nm, fibra linear e baixa Cronos Pro Italic 
12 pt/ 14,4 pt - C0 M0 Y0 K100 
Resumo 

Keywords:
Cronos Pro Semibold 
11 pt/ 13 pt - C0 M0 Y0 K100 
Cronos Pro Light 
9 pt/ 11 pt - C0 M0 Y0 K100 
ablation techniques; laser therapy; varicose veins. 

5 mm 

Contexto: O laser de diodo 1470 nm, com comprimento de onda específico para água, tendo como alvo a água 
intersticial da parede venosa, poderia causar ablação venosa a densidades de energia menores e com menos efeitos 
colaterais. Objetivos: Determinar a taxa de obliteração da veia safena magna (VSM) após termoablação com laser 
1470 nm utilizando 7 W de potência e avaliar a evolução clínica e as complicações. Métodos: Dezenove pacientes 
(31 VSMs) foram submetidos a termoablação e reexaminados através de ecodoppler, avaliação clínica utilizando 

o Venous Clinical Severity Score (VCSS) e avaliação das complicações do procedimento entre 3 e 5 dias e aos 
30 e 180 dias de pós-operatório. Resultados: A média de idade dos pacientes foi de 46 anos; 17 eram mulheres 
(89,47%). Deacordo com a classificação de Clinical-Etiology-Anatomy-Physiopathology (CEAP), 2 dos 31 membros 
tratados eram C2, 19 eram C3, 9 eram C4 e 1 membro era C5. A densidade de energia linear endovenosa média foi 
de 33,53J/cm. A taxa de obliteração da VSM foi de 93,5% no pós-operatório imediato, de 100% entre 3 e 5 dias e aos 
Cronos Pro Light 
9 pt/ 11 pt - C0 M0 Y0 K100 
19,5 mm 
30 dias, e de 87,1% aos 180 dias. Houve uma redução significativa dos valores de VCSS em todos os momentos de 
avaliação. Conclusões: Os dados deste estudo apoiam a possibilidade de que, utilizando baixa densidade de energia, 
podemos reduzir a incidência de complicações sem afetar significativamente o resultado clínico. No entanto, isso 
parece ocorrer às custas da diminuição da eficácia em termos de taxa de obliteração da VSM. 

2,5 mm 

31,5 mm 

18 mm 

Submitted: June 05, 2015. Accepted: June 26, 2015. 

2 mm 

12 mm 

http://dx.doi.org/10.1590/1677-5449.004015 
J Vasc Bras. 2015 Oct.-Dec.; 14(4):281-288 281 
Cronos Pro Bold 
8,5 pt/ 10,2 pt - C0 M0 Y0 K100 

e study was carried out at Hospital de Clínicas, Universidade Federal do Paraná (UFPR), Curitiba, PR, Brazil. 
Cronos Pro Regular 
7 pt/ 8 pt - C0 M0 Y0 K100 
Cronos Pro Light 
8 pt/ 9,6 pt - C0 M0 Y0 K100Cronos Pro Light 
8 pt/ 9,6 pt - C0 M0 Y0 K100 

9,5 mm 

7 mm 

8,5 mm 

Palavras-chave: técnicas de ablação; terapia a laser; varizes. 
Cronos Pro Light 
9 pt/ 11 pt - C0 M0 Y0 K100 
1 Universidade Federal do Paraná – UFPR, Department of Surgery, Curitiba, PR, Brazil. 
Financial support: None. 
Conflicts of interest: No conflicts of interest declared concerning the publication of this article. 
Cronos Pro Light 
7 pt/ 8 pt - C0 M0 Y0 K100 

5 mm 

11 mm 

23 mm 

Walter Junior Boim Araujo, Jorge Rufino Ribas Timietal. 
Cronos Pro Light 
8 pt/ 9,6 pt - C0 M0 Y0 K100 

9,5 mm 

EVLA.9,10.................................................................................. 


........................................................................................................ 
........................................................................................................ 


...................................................................................................... 
18 mm .............................................................................................. 
............................................................................................
Times New Roman Regular 
10 pt/ 12 pt - C0 M0 Y0 K100 

............................................................................................ 
.......................... 
................................................................................................ 


.................................................................................................... 


.................................................................................................. 
......................................................................11 


................................11.............................................................. 
........................12.............................................................. 


6,5 mm .................................................................................................... 
.......................................................................................................... 
........................................................................................................ 
................................................................ 


.................................................................................................. 
.................................................................................................. 
................................................................................................................ 
.................................................................................................. 
.................................................................................................................. 
.......................................................................................... 
............................................................................ 


...................................................................................... 


1,5 mm 

............................................................................................ 


6,5 mm 

................................................................................................ 


Figure 4. Venous Clinical Severity Scores (VCSS) over time. 

Table 2. Pairwise comparison of GSV diameters measured at 
Cronos Pro Light 
9 pt/ 10,8 pt - C0 M0 Y0 K100 
........................................................................................ 


the SFJ, thigh, and knee at dierent time points. .................................................................................................. 


Time points compared SFJ igh Knee .............................................................................................................. 


Preop × 3-5 days 0.330 0.902 0.476 ........................................................................................................ 


Preop × 1 month 0.386 0.110 0.091 .................................................................................................. 


Preop × 6 months 0.001 <0.001 0.001 ........................................................................................................ 


3-5 days × 1 month 0.068 0.140 0.017 ........................................................................................................ 
12 mm 

3-5 days × 6 months <0.001 <0.001 <0.001 ............................................................................................ 


1 month × 6 months 0.014 <0.001 0.091 ...................................................................................................... 


GSV: great saphenous vein; SFJ: saphenofemoral junction. 

............................................ 


9 mm 

Table 3. Length of ablated GSV versus occlusion rate at 6 months. 


Occlusion at Length of ablated GSV 

p-value* 

6 months n Mean Median Minimum Maximum SD 

No 435 35 30 40 5.8 0.237 
Yes 2731 28 15 50 9.8 

GSV: great saphenous vein; SD: standard deviation. *Nonparametric Mann-Whitney; p<0.05. 

Table 4. Procedure-related complications. 

No 

Yes 

Variable 

Total 

n%n% 

DVT – 3-5 days 31 100.0% 0 0.0% 31 
DVT – 1 month 31 100.0% 0 0.0% 31 
DVT – 6 months 31 100.0% 0 0.0% 31 
Phlebitis – 3-5 days 31 100.0% 0 0.0% 31 
Phlebitis – 1 month 30 96.8% 1 3.2% 31 
Phlebitis – 6 months 31 100.0% 0 0.0% 31 
Paresthesia – 3-5 days 28 90.3% 3 9.7% 31 
Paresthesia – 1 month 29 93.5% 2 6.5% 31 
Paresthesia – 6 months 31 100.0% 0 0.0% 31 


180 x 265 mm 

DVT: deep vein thrombosis. 

J Vasc Bras. 2015 Oct.-Dec.; 14(4):281-288 285

18 mm 



Walter Junior Boim Araujo, Jorge Rufino Ribas Timietal. 

180 x 265 mm 

........................................................................................................ 
........................................................ 


.......................................................................................................... 
.................................................................................................... 
..........................................................................................................20 
....................21...................................................................................... 
...................................................................................................... 
................................................................................................ 
.......................................................................................................... 
................................................................................................ 
.................................................................................................. 
.............................................................................................. 
.................................................................................................................. 
...................................................................................................... 
.......................................................................................................... 
............................................................................................................ 
...................................................................................................... 
.......................................................................................... 
........................................................................................................ 
...................................................................................................... 
........................................................................................................ 
.............................................................................................. 
.............................................................................................................. 
.............................. 


CONCLUSION 


.................................................................................................. 
.................................................................................................................................................................................................................... 
................................................................................................ 
...................................................................................................... 
.................................................................................................... 
............................................................................................................ 
................................................................................................ 
.......................................................................................................... 


............................................ 


5,5 mm 

REFERENCES 
Cronos Pro Bold 
11 pt/ 13 pt - C0 M0 Y0 K100 

4,5 mm 

1. 
Evans CJ, Fowkes FG, Ruckley CV, Lee AJ. Prevalence of varicose 
veins and chronic venous insufficiency in men and women in the 
general population: Edinburgh Vein Study. J Epidemiol Community 
Health. 1999;53(3):149-53. http://dx.doi.org/10.1136/jech.53.3.149. 
PMid:10396491. 
2,5 mm 

3. 
van den Bos R, Arends L, Kockaert M, Neumann M, Nijsten T. 
Endovenous therapies of lower extremity varicosities: a metaanalysis. 
J Vasc Surg. 2009;49(1):230-9. http://dx.doi.org/10.1016/j. 
jvs.2008.06.030. PMid:18692348. 
2. 
Andreozzi GM, Cordova RM, Scomparin A,etal. Quality of life in 
chronic venous insufficiency. An Italian pilot study of the Triveneto 
Region. Int Angiol. 2005;24(3):272-7. PMid:16158038. Cronos Pro Regular 
8 pt/ 9,6 pt - C0 M0 Y0 K100 
4. 
Boné Salat CB. Tratamiento endoluminal de las varices con laser 
de diodo: estudio preliminar. Rev Patol Vasc. 1999;5:35-46. 

5. 
Navarro L, Min RJ, Bone C. Endovenous laser: a new minimally 
invasive method of treatment for varicose veins--preliminary 

observations using an 810 nm diode laser. Dermatol Surg. 
2001;27(2):117-22. PMid:11207682. 

6. 
Pannier F, Rabe E, Maurins U. First results with a new 1470-nm 
diode laser for endovenous ablation of incompetent saphenous 
veins. Phlebology. 2009;24(1):26-30. http://dx.doi.org/10.1258/ 
phleb.2008.008038. PMid:19155338. 
7. 
Almeida J, Mackay E, Javier J, Mauriello J, Raines J. Saphenous 
laser ablation at 1470 nm targets the vein wall, not blood. 
Vasc Endovascular Surg. 2009;43(5):467-72. http://dx.doi. 
org/10.1177/1538574409335916. PMid:19628516. 
8. 
Proebstle TM, Gül D, Lehr HA, Kargl A, Knop J. Infrequent early 
recanalization of greater saphenous vein after endovenous laser 
treatment. J Vasc Surg. 2003;38(3):511-6. http://dx.doi.org/10.1016/ 
S0741-5214(03)00420-8. PMid:12947269. 
9. 
Proebstle TM, Moehler T, Gul D, Herdemann S. Endovenous 
treatment of the great saphenous vein using a 1,320 nm Nd:YAG 
laser causes fewer side effects than using a 940 nm diode laser. 
Dermatol Surg. 2005;31:1678-83. 
10. Timperman PE. Prospective evaluation of higher energy great 
saphenous vein endovenous laser treatment. J Vasc Interv Radiol. 
2005;16(6):791-4. http://dx.doi.org/10.1097/01.RVI.0000165044.41012. 
C8. PMid:15947042. 
11. Timperman PE, Sichlau M, Ryu RK. Greater energy delivery improves 
treatment success of endovenous laser treatment of incompetent 
saphenous veins. J Vasc Interv Radiol. 2004;15(10):1061-3. http:// 
dx.doi.org/10.1097/01.RVI.0000130382.62141.AE. PMid:15466791. 
12. Bueno KS, Albernaz DT, Albernaz LF, Zignani FR. Endolaser venoso: 
estudo série de casos. J Vasc Bras. 2012;11(4):286-8. http://dx.doi. 
org/10.1590/S1677-54492012000400006. 
13. Park JA, Park SW, Chang IS,etal. The 1,470-nm bare-fiber diode 
laser ablation of the great saphenous vein and small saphenous vein 
at 1-year follow-up using 8-12 W and a mean linear endovenous 
energy density of 72 J/cm. J Vasc Interv Radiol. 2014;25(11):1795800. 
http://dx.doi.org/10.1016/j.jvir.2014.07.009. PMid:25156646. 
14. Proebstle TM, Lehr HA, Kargl A,etal. Endovenous treatment of 
the greater saphenous vein with a 940-nm diode laser: thrombotic 
occlusion after endoluminal thermal damage by laser-generated 
steam bubbles. J Vasc Surg. 2002;35(4):729-36. http://dx.doi. 
org/10.1067/mva.2002.121132. PMid:11932671. 
15. Schmedt CG, Sroka R, Steckmeier S, etal. Investigation on 
radiofrequency and laser (980 nm) effects after endoluminal 
treatment of saphenous vein insufficiency in an ex-vivo model. 
Eur J Vasc Endovasc Surg. 2006;32(3):318-25. http://dx.doi. 
org/10.1016/j.ejvs.2006.04.013. PMid:16781172. 
16. Hirokawa M, Kurihara N. Comparison of bare-tip and radial fiber 
in endovenous laser ablation with 1470 nm diode laser. Ann Vasc 
Dis. 2014;7(3):239-45. http://dx.doi.org/10.3400/avd.oa.14-00081. 
PMid:25298824. 
17. Puggioni A, Kalra M, Carmo M, Mozes G, Gloviczki P. Endovenous 
laser therapy and radiofrequency ablation of the great saphenous 
vein: analysis of early efficacy and complications. J Vasc Surg. 
2005;42(3):488-93. http://dx.doi.org/10.1016/j.jvs.2005.05.014. 
PMid:16171593. 
18. Sufian S, Arnez A, Labropoulos N, Lakhanpal S. Endovenous heatinduced 
thrombosis after ablation with 1470 nm laser: Incidence, 
progression, and risk factors. Phlebology. 2014;30(5):325-30. 
PMid:24609619. 
19. Dexter D, Kabnick L, Berland T,etal. Complications of endovenous 
lasers. Phlebology. 2012;27(Suppl 1):40-5. http://dx.doi.org/10.1258/ 
phleb.2012.012S18. PMid:22312066. 
20. Proebstle TM, Moehler T, Herdemann S. Reduced recanalization 
rates of the great saphenous vein after endovenous laser treatment 
J Vasc Bras. 2015 Oct.-Dec.; 14(4):281-288 287 


4 mm 



